Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 281-591-4 | CAS number: 83969-14-6
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity
LD50 (male) = 395 mg/kg bw.
LD50 (female) = 275 mg/kg bw.
Acute dermal toxicity
LD0 = 2000 mg(kg
LD50 > 2000 mg/kg
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 275 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
Justification for classification or non-classification
According to the CLP Regulation (EC 1272/2008), table 3.1.1, acute toxicity hazard categories and acute toxicity estimates (ATE) defining the respective categories:
For acute toxicity by oral route:
category 1: ATE <= 5 mg/kg bw
category 2: 5 < ATE <= 50 mg/kg bw
category 3: 50 < ATE <= 300 mg/kg bw
category 4: 300 < ATE <= 2000 mg/kg bw
For acute toxicity by dermal route:
category 1: ATE <= 50 mg/kg bw
category 2: 50 < ATE <= 200 mg/kg bw
category 3: 200 < ATE <= 1000 mg/kg bw
category 4: 1000 < ATE <= 2000 mg/kg bw
Based on available information, target substance is classified as category 3 (H301) for acute oral toxicity, while it is not classified for acute dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
